Logo image of COVH.PA

COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:COVH - FR0000060303 - REIT

22.8 EUR
-0.1 (-0.44%)
Last: 1/12/2026, 10:49:27 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to COVH. COVH was compared to 42 industry peers in the Diversified REITs industry. Both the profitability and the financial health of COVH get a neutral evaluation. Nothing too spectacular is happening here. COVH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year COVH was profitable.
COVH had a positive operating cash flow in the past year.
In multiple years COVH reported negative net income over the last 5 years.
In the past 5 years COVH always reported a positive cash flow from operatings.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

COVH's Return On Assets of 2.88% is in line compared to the rest of the industry. COVH outperforms 59.52% of its industry peers.
COVH's Return On Equity of 5.87% is fine compared to the rest of the industry. COVH outperforms 61.90% of its industry peers.
COVH has a Return On Invested Capital of 3.67%. This is comparable to the rest of the industry: COVH outperforms 57.14% of its industry peers.
COVH had an Average Return On Invested Capital over the past 3 years of 3.85%. This is in line with the industry average of 3.45%.
Industry RankSector Rank
ROA 2.88%
ROE 5.87%
ROIC 3.67%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

The Profit Margin of COVH (78.86%) is better than 88.10% of its industry peers.
In the last couple of years the Profit Margin of COVH has declined.
COVH has a better Operating Margin (101.41%) than 97.62% of its industry peers.
In the last couple of years the Operating Margin of COVH has remained more or less at the same level.
Industry RankSector Rank
OM 101.41%
PM (TTM) 78.86%
GM N/A
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

COVH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, COVH has about the same amount of shares outstanding.
The number of shares outstanding for COVH has been increased compared to 5 years ago.
COVH has a worse debt/assets ratio than last year.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.02, we must say that COVH is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of COVH (1.02) is better than 66.67% of its industry peers.
The Debt to FCF ratio of COVH is 12.71, which is on the high side as it means it would take COVH, 12.71 years of fcf income to pay off all of its debts.
COVH has a Debt to FCF ratio (12.71) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.70 indicates that COVH is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.70, COVH perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Altman-Z 1.02
ROIC/WACC0.69
WACC5.33%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.16 indicates that COVH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.16, COVH belongs to the top of the industry, outperforming 88.10% of the companies in the same industry.
COVH has a Quick Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.16, COVH belongs to the top of the industry, outperforming 88.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 242.64% over the past year.
Measured over the past years, COVH shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.16% on average per year.
COVH shows a decrease in Revenue. In the last year, the revenue decreased by -5.26%.
Measured over the past years, COVH shows a small growth in Revenue. The Revenue has been growing by 2.29% on average per year.
EPS 1Y (TTM)242.64%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%

3.2 Future

The Earnings Per Share is expected to grow by 0.90% on average over the next years.
The Revenue is expected to grow by 0.55% on average over the next years.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.52, which indicates a correct valuation of COVH.
COVH's Price/Earnings is on the same level as the industry average.
COVH is valuated rather cheaply when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 13.23 indicates a correct valuation of COVH.
COVH's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. COVH is more expensive than 61.90% of the companies in the same industry.
COVH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.92, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.52
Fwd PE 13.23
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, COVH is valued a bit cheaper than the industry average as 61.90% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as COVH.
Industry RankSector Rank
P/FCF 15.57
EV/EBITDA 16.85
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.49
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

COVH has a Yearly Dividend Yield of 6.52%, which is a nice return.
Compared to an average industry Dividend Yield of 4.99, COVH pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.92, COVH pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.52%

5.2 History

The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

19.17% of the earnings are spent on dividend by COVH. This is a low number and sustainable payout ratio.
DP19.17%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVIVIO HOTELS SACA

EPA:COVH (1/12/2026, 10:49:27 AM)

22.8

-0.1 (-0.44%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22 2025-10-22
Earnings (Next)02-16 2026-02-16
Inst Owners31.31%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.60B
Revenue(TTM)260.60M
Net Income(TTM)205.50M
Analysts82.86
Price Target18.67 (-18.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.52%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.17%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.52
Fwd PE 13.23
P/S 13.82
P/FCF 15.57
P/OCF 9.85
P/B 1.03
P/tB 1.14
EV/EBITDA 16.85
EPS(TTM)1.38
EY6.05%
EPS(NY)1.72
Fwd EY7.56%
FCF(TTM)1.46
FCFY6.42%
OCF(TTM)2.32
OCFY10.15%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)5.49
PEG (5Y)N/A
Graham Number26.22
Profitability
Industry RankSector Rank
ROA 2.88%
ROE 5.87%
ROCE 4.15%
ROIC 3.67%
ROICexc 4.06%
ROICexgc 4.3%
OM 101.41%
PM (TTM) 78.86%
GM N/A
FCFM 88.79%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexgc growth 3Y33.75%
ROICexgc growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.71
Debt/EBITDA 6.96
Cap/Depr 151.01%
Cap/Sales 51.57%
Interest Coverage 4.11
Cash Conversion 103.55%
Profit Quality 112.6%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.02
F-Score5
WACC5.33%
ROIC/WACC0.69
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)242.64%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.66%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.4%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y24.44%
OCF growth 3Y30.01%
OCF growth 5Y4.76%

COVIVIO HOTELS SACA / COVH.PA FAQ

What is the fundamental rating for COVH stock?

ChartMill assigns a fundamental rating of 4 / 10 to COVH.PA.


What is the valuation status of COVIVIO HOTELS SACA (COVH.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to COVIVIO HOTELS SACA (COVH.PA). This can be considered as Overvalued.


How profitable is COVIVIO HOTELS SACA (COVH.PA) stock?

COVIVIO HOTELS SACA (COVH.PA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for COVH stock?

The Price/Earnings (PE) ratio for COVIVIO HOTELS SACA (COVH.PA) is 16.52 and the Price/Book (PB) ratio is 1.03.


Can you provide the expected EPS growth for COVH stock?

The Earnings per Share (EPS) of COVIVIO HOTELS SACA (COVH.PA) is expected to grow by 3.01% in the next year.